170 related articles for article (PubMed ID: 37887994)
1. Expression, Function and Trafficking of the Human ABCG2 Multidrug Transporter Containing Mutations in an Unstructured Cytoplasmic Loop.
Mózner O; Zámbó B; Bartos Z; Gergely A; Szabó KS; Jezsó B; Telbisz Á; Várady G; Homolya L; Hegedűs T; Sarkadi B
Membranes (Basel); 2023 Oct; 13(10):. PubMed ID: 37887994
[TBL] [Abstract][Full Text] [Related]
2. Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter.
Zámbó B; Mózner O; Bartos Z; Török G; Várady G; Telbisz Á; Homolya L; Orbán TI; Sarkadi B
Cell Mol Life Sci; 2020 Jan; 77(2):365-378. PubMed ID: 31254042
[TBL] [Abstract][Full Text] [Related]
3. Cellular Processing of the ABCG2 Transporter-Potential Effects on Gout and Drug Metabolism.
Mózner O; Bartos Z; Zámbó B; Homolya L; Hegedűs T; Sarkadi B
Cells; 2019 Oct; 8(10):. PubMed ID: 31597297
[TBL] [Abstract][Full Text] [Related]
4. The ABCG2/BCRP transporter and its variants - from structure to pathology.
Sarkadi B; Homolya L; Hegedűs T
FEBS Lett; 2020 Dec; 594(23):4012-4034. PubMed ID: 33015850
[TBL] [Abstract][Full Text] [Related]
5. Identification of Specific Trafficking Defects of Naturally Occurring Variants of the Human ABCG2 Transporter.
Bartos Z; Homolya L
Front Cell Dev Biol; 2021; 9():615729. PubMed ID: 33634118
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
Mizuarai S; Aozasa N; Kotani H
Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
[TBL] [Abstract][Full Text] [Related]
7. Medically Important Alterations in Transport Function and Trafficking of ABCG2.
Homolya L
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801813
[TBL] [Abstract][Full Text] [Related]
8. Effects of the gout-causing Q141K polymorphism and a CFTR ΔF508 mimicking mutation on the processing and stability of the ABCG2 protein.
Sarankó H; Tordai H; Telbisz Á; Özvegy-Laczka C; Erdős G; Sarkadi B; Hegedűs T
Biochem Biophys Res Commun; 2013 Jul; 437(1):140-5. PubMed ID: 23800412
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).
Meyer zu Schwabedissen HE; Kroemer HK
Handb Exp Pharmacol; 2011; (201):325-71. PubMed ID: 21103975
[TBL] [Abstract][Full Text] [Related]
10. Jump into a New Fold-A Homology Based Model for the ABCG2/BCRP Multidrug Transporter.
László L; Sarkadi B; Hegedűs T
PLoS One; 2016; 11(10):e0164426. PubMed ID: 27741279
[TBL] [Abstract][Full Text] [Related]
11. N-Linked glycosylation of the human ABC transporter ABCG2 on asparagine 596 is not essential for expression, transport activity, or trafficking to the plasma membrane.
Diop NK; Hrycyna CA
Biochemistry; 2005 Apr; 44(14):5420-9. PubMed ID: 15807535
[TBL] [Abstract][Full Text] [Related]
12. Functional Characterization of Clinically-Relevant Rare Variants in
Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
[TBL] [Abstract][Full Text] [Related]
13. The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology.
Cervenak J; Andrikovics H; Ozvegy-Laczka C; Tordai A; Német K; Váradi A; Sarkadi B
Cancer Lett; 2006 Mar; 234(1):62-72. PubMed ID: 16337740
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites.
Telbisz Á; Hegedüs C; Váradi A; Sarkadi B; Özvegy-Laczka C
Drug Metab Dispos; 2014 Apr; 42(4):575-85. PubMed ID: 24384916
[TBL] [Abstract][Full Text] [Related]
15. Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression.
Zámbó B; Bartos Z; Mózner O; Szabó E; Várady G; Poór G; Pálinkás M; Andrikovics H; Hegedűs T; Homolya L; Sarkadi B
Sci Rep; 2018 May; 8(1):7487. PubMed ID: 29749379
[TBL] [Abstract][Full Text] [Related]
16. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.
Daood M; Tsai C; Ahdab-Barmada M; Watchko JF
Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane Domain Single-Nucleotide Polymorphisms Impair Expression and Transport Activity of ABC Transporter ABCG2.
Sjöstedt N; van den Heuvel JJMW; Koenderink JB; Kidron H
Pharm Res; 2017 Aug; 34(8):1626-1636. PubMed ID: 28281205
[TBL] [Abstract][Full Text] [Related]
18. Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics.
Noguchi K; Katayama K; Sugimoto Y
Pharmgenomics Pers Med; 2014; 7():53-64. PubMed ID: 24523596
[TBL] [Abstract][Full Text] [Related]
19. Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter.
Telbisz A; Müller M; Ozvegy-Laczka C; Homolya L; Szente L; Váradi A; Sarkadi B
Biochim Biophys Acta; 2007 Nov; 1768(11):2698-713. PubMed ID: 17662239
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.
Pál A; Méhn D; Molnár E; Gedey S; Mészáros P; Nagy T; Glavinas H; Janáky T; von Richter O; Báthori G; Szente L; Krajcsi P
J Pharmacol Exp Ther; 2007 Jun; 321(3):1085-94. PubMed ID: 17347325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
